Tanycytic networks mediate energy balance by feeding lactate to glucose-insensitive POMC neurons.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
15 09 2021
Historique:
received: 21 05 2020
accepted: 28 07 2021
pubmed: 30 7 2021
medline: 16 11 2021
entrez: 29 7 2021
Statut: ppublish

Résumé

Hypothalamic glucose sensing enables an organism to match energy expenditure and food intake to circulating levels of glucose, the main energy source of the brain. Here, we established that tanycytes of the arcuate nucleus of the hypothalamus, specialized glia that line the wall of the third ventricle, convert brain glucose supplies into lactate that they transmit through monocarboxylate transporters to arcuate proopiomelanocortin neurons, which integrate this signal to drive their activity and to adapt the metabolic response to meet physiological demands. Furthermore, this transmission required the formation of extensive connexin-43 gap junction-mediated metabolic networks by arcuate tanycytes. Selective suppression of either tanycytic monocarboxylate transporters or gap junctions resulted in altered feeding behavior and energy metabolism. Tanycytic intercellular communication and lactate production are thus integral to the mechanism by which hypothalamic neurons that regulate energy and glucose homeostasis efficiently perceive alterations in systemic glucose levels as a function of the physiological state of the organism.

Identifiants

pubmed: 34324439
pii: e140521
doi: 10.1172/JCI140521
pmc: PMC8439611
doi:
pii:

Substances chimiques

Monocarboxylic Acid Transporters 0
Muscle Proteins 0
Slc16a4 protein, mouse 0
Symporters 0
monocarboxylate transport protein 1 0
Lactic Acid 33X04XA5AT
Pro-Opiomelanocortin 66796-54-1
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Research Council
ID : 810331
Pays : International

Commentaires et corrections

Type : CommentIn

Références

Nat Methods. 2011 Dec 28;9(1):57-63
pubmed: 22205519
Brain Res. 2017 Oct 15;1673:64-71
pubmed: 28803831
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4695-700
pubmed: 15070780
Nat Neurosci. 2019 Jan;22(1):7-14
pubmed: 30531847
Nat Rev Neurosci. 2018 Apr;19(4):235-249
pubmed: 29515192
J Neurosci. 2003 Nov 19;23(33):10622-32
pubmed: 14627647
Biochem Biophys Res Commun. 2009 Aug 14;386(1):212-6
pubmed: 19523445
Nat Neurosci. 2016 Feb;19(2):206-19
pubmed: 26814590
Diabetes Metab. 2014 Jun;40(3):191-7
pubmed: 24332017
Am J Physiol. 1964 Apr;206:836-44
pubmed: 14166182
Int J Obes Relat Metab Disord. 2004 Dec;28 Suppl 4:S22-8
pubmed: 15592482
Am J Physiol Regul Integr Comp Physiol. 2005 Jul;289(1):R247-58
pubmed: 15746303
PLoS One. 2013 Apr 26;8(4):e62532
pubmed: 23638108
Cell Rep. 2020 Mar 3;30(9):3067-3078.e5
pubmed: 32130907
Nat Commun. 2015 Feb 27;6:6385
pubmed: 25721933
J Physiol. 2011 May 1;589(Pt 9):2275-86
pubmed: 21486800
Front Cell Neurosci. 2018 Nov 26;12:406
pubmed: 30534054
Glia. 2011 Nov;59(11):1695-705
pubmed: 21769945
Cell Metab. 2006 Feb;3(2):135-40
pubmed: 16459314
J Mol Med (Berl). 2019 Aug;97(8):1085-1097
pubmed: 31129757
J Neurosci. 2009 May 27;29(21):7015-22
pubmed: 19474328
Cell Metab. 2013 Apr 2;17(4):607-17
pubmed: 23562080
Cell Metab. 2021 Jun 1;33(6):1155-1170.e10
pubmed: 33951475
J Neurosci. 2013 Feb 20;33(8):3624-32
pubmed: 23426689
Cell Metab. 2007 Oct;6(4):252-4
pubmed: 17908553
J Cell Mol Med. 2015 Jul;19(7):1471-82
pubmed: 26081217
Am J Physiol. 1988 Aug;255(2 Pt 2):R200-4
pubmed: 3044143
Redox Biol. 2021 May;41:101945
pubmed: 33744652
Nat Neurosci. 2016 Jun;19(6):835-44
pubmed: 27135215
Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E491-6
pubmed: 18577696
PLoS One. 2011 Jan 28;6(1):e16411
pubmed: 21297988
Nature. 2007 Sep 13;449(7159):228-32
pubmed: 17728716
Science. 1964 Jan 31;143(3605):484-5
pubmed: 14080319
Cells. 2020 Oct 31;9(11):
pubmed: 33142723
Diabetes. 2004 May;53(5):1230-6
pubmed: 15111491
Science. 1988 Jul 22;241(4864):462-4
pubmed: 3260686
Cell. 1997 Jan 10;88(1):131-41
pubmed: 9019399
Diabetes. 2007 May;56(5):1219-27
pubmed: 17261674
Hum Mol Genet. 2006 Apr 1;15(7):1169-79
pubmed: 16497725
JAMA Neurol. 2013 Nov;70(11):1440-4
pubmed: 23999624
Nat Commun. 2018 Sep 21;9(1):3846
pubmed: 30242148
Diabetes. 2004 Oct;53(10):2521-8
pubmed: 15448079
Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10625-9
pubmed: 7938003
Science. 2008 Dec 5;322(5907):1551-5
pubmed: 19056987
Nat Med. 1999 Sep;5(9):1066-70
pubmed: 10470087
J Clin Invest. 2007 Aug;117(8):2325-36
pubmed: 17671657
Nat Metab. 2021 Aug;3(8):1071-1090
pubmed: 34341568
Cell Metab. 2014 Feb 4;19(2):293-301
pubmed: 24506870
Diabetes. 2019 Dec;68(12):2210-2222
pubmed: 31530579
Cell. 2016 Aug 11;166(4):867-880
pubmed: 27518562
N Engl J Med. 2012 Feb 9;366(6):576-8
pubmed: 22316468
Neuron. 2017 Sep 13;95(6):1365-1380.e5
pubmed: 28867552
Science. 2005 Aug 5;309(5736):943-7
pubmed: 16081739
N Engl J Med. 1991 Sep 5;325(10):703-9
pubmed: 1714544
Cell Metab. 2016 Jan 12;23(1):94-102
pubmed: 26698914
Mol Neurobiol. 2020 Aug;57(8):3307-3333
pubmed: 32519243
Cell. 2015 Mar 26;161(1):133-145
pubmed: 25815991
N Engl J Med. 1953 Jul 2;249(1):13-6
pubmed: 13063674
Endocr Rev. 2018 Jun 1;39(3):333-368
pubmed: 29351662
Cell Metab. 2015 Oct 6;22(4):646-57
pubmed: 26278050
Nat Commun. 2017 Sep 7;8(1):484
pubmed: 28883467
J Neurosci. 2010 Jun 16;30(24):8061-70
pubmed: 20554857

Auteurs

Tori Lhomme (T)

University Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience and Cognition, UMR-S 1172, European Genomic Institute of Diabetes (EGID) and Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease (DISTALZ), Lille, France.

Jerome Clasadonte (J)

University Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience and Cognition, UMR-S 1172, European Genomic Institute of Diabetes (EGID) and Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease (DISTALZ), Lille, France.

Monica Imbernon (M)

University Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience and Cognition, UMR-S 1172, European Genomic Institute of Diabetes (EGID) and Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease (DISTALZ), Lille, France.

Daniela Fernandois (D)

University Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience and Cognition, UMR-S 1172, European Genomic Institute of Diabetes (EGID) and Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease (DISTALZ), Lille, France.

Florent Sauve (F)

University Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience and Cognition, UMR-S 1172, European Genomic Institute of Diabetes (EGID) and Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease (DISTALZ), Lille, France.

Emilie Caron (E)

University Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience and Cognition, UMR-S 1172, European Genomic Institute of Diabetes (EGID) and Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease (DISTALZ), Lille, France.

Natalia da Silva Lima (N)

CIMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.

Violeta Heras (V)

CIMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.

Ines Martinez-Corral (I)

University Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience and Cognition, UMR-S 1172, European Genomic Institute of Diabetes (EGID) and Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease (DISTALZ), Lille, France.

Helge Mueller-Fielitz (H)

Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany.

Sowmyalakshmi Rasika (S)

University Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience and Cognition, UMR-S 1172, European Genomic Institute of Diabetes (EGID) and Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease (DISTALZ), Lille, France.

Markus Schwaninger (M)

Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany.

Ruben Nogueiras (R)

CIMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.

Vincent Prevot (V)

University Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience and Cognition, UMR-S 1172, European Genomic Institute of Diabetes (EGID) and Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease (DISTALZ), Lille, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH